Bragar Eagel & Squire, P.C. is investigating potential claims against Hims & Hers Health, Inc. on behalf of stockholders. The investigation concerns whether Hims & Hers violated federal securities laws or engaged in other unlawful business practices. The inquiry follows a July 29, 2026 lawsuit by the Federal Trade Commission, the People of the State of California, and the Utah Division of Consumer Protection alleging that Hims & Hers failed to clearly disclose prescription charges, made cancellations difficult, and shared consumers' health information with third parties. After the news, Hims & Hers stock fell $4.32 per share, or 14.73%, to close at $25.00 per share on July 29, 2026. The law firm encourages investors who suffered losses to contact them.
